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some instability (Jaspers et al. 1988), suggesting that 
the same pathway (or part thereof) is impaired in bolli 
syndromes. The underlying gene for NBS has not yet 
been identified, and its location in the human genome
is still unknown.
The genetic complementation groups were defined by 
somatic cell fusion between AT cells from different AT 
patients: if the fused cells retained RDS, then the two
patients belonged to the same groups. Each genetic com-
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The Gene for Nijmegen Breakage Syndrome (V2) Is 
Not Located on Chromosome 11
To the Editor:
plementation group within classical A l as 
were believed to arise from different* mutated genes or 
at least from different mutations within one or several 
genes. FI owe ver, the recently cloned ATM gene was 
found to be mutated in all complementation groups of 
AT, without any correlation to whatever the comple­
mentation group, indicating that, at least in classical AT, 
only one single gene is involved (Savitsky et al. 1995). 
Whether the same ATM gene is also involved in NBS 
remains, as yet, unclear, since the complementation 
studies based on the restoration of RDS obviously give 
conflicting results (Komatsu st ah 1989; Verhaegh et 
al. 1993, 1995; Zdzienicka et a l  1994; Savitsky et al. 
1995).
To further study the genetic complementation of NBS 
and AT on the basis of high-radiation sensitivity of both 
diseases, we transformed several primary cultures of 
NBS skin fibroblasts with SV40 virus, and an immortal 
cell line was successfully established only from GM7166 
cells belonging to AT-V2. The passage number of these 
GM7166VA7 cells is presently 80, and the life span was 
sufficiently long to allow them to be used for subcloning 
of somatic-cell and microcell hybrid, In addition, the 
radiation sensitivity of GM7166VA7 cells was nearly
Ataxia telangiectasia (AT) is an autosomal recessive dis- the same as that of the parental primary cultures.
Using the GM 7166VA7 cell line, we examined the 
genetic heterogeneity of NBS V2 and classical AT by 
an introduction of chromosome via microcell-mediated
order characterized by oculocutaneous telangiectasia 
and cerebellar ataxia. Individuals with this disorder dis­
play immunological impairments, hypersensitivity to 
ionizing radiation, and a predisposition to cancer (for chromosome transfer. A single copy of human chromo- 
reviews, see Shiloh 1995). There has been reported ge- some 11 was introduced into GM7166VA7 cells, and 
netic heterogeneity in AT, which appeared to include the karyotypes of the resulting G418-resistant clones
four genetic complementation groups in classical AT were analyzed. Figure 1 shows metaphase chromosomes
i.e., A, B/C, D, E— and two variants, so-called Nijmegen of GM7166VA7 cells and the microcell hybrid clone 11/ 
breakage syndrome (NBS), VI and V2 (Murnane and 1. GM7166VA7 cells contained two chromosomes 11, 
Painter 1982; Jaspers et al. 1988). Among the four whereas the microcell hybrid clone 11/1 revealed a tri­
groups of classical AT, no significant differences in clini- somy of chromosome 11 in 80% of the cells and a di- 
cal appearance have been seen. Familial linkage analyses somy in the remaining 20%. This disomy probably was 
have produced evidence that genes for all four compie- the result of loss of either of the original parental chro- 
mentation groups in classical AT reside in a narrow mosomes 11 or of the introduced chromosome 11, as 
region on chromosome Hq22-23 (Gatti et al. 1988; has been previously observed in chromosome transfers
McConville et al. 1994). On the other hand, NBS pa­
tients have neither cerebellar ataxia nor telangiectasia 
but do display microcephaly and a developmental delay 
(Weemaes et al, '1981; Wegner et al. 1988). Flowever, 
patients share features with AT, such as high radiosensi­
tivity, radioresistant DNA synthesis (RDS), and chromo-
to AT5BIVA cells (Komatsu et aL 1990). In order to 
confirm the presence of chromosome 11 derived from 
A 9 (n e o ll) - l  in the microcell hybrid clone, CA-repeat 
polymorphisms at the D11S420 locus on human 
chromosome Tiq23>3*-24 were analyzed in 
GM7166VA7 recipient cells and A9(neoH)-'I donor
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Figure 1 Representative CïTG-stained metaphase spreads of i\ parental GM7166VA7 cell (A) and a microccll hybrid from clone 11/1, 
which contains an additional copy of a normal human chromosome 11 (B),
cells. Since CA-repeat lengths in these cell lines were 
different by two bases, the origin of the chromosome
11 copies in the hybrid clones could be identified as 
coming from either the recipient cells or the donor cells. 
Both hybrid clones, 11/1 and 11/41, contained two main 
bands in this assay, which indicated that at least one 
single chromosome 11 from the A9(neol 1)-1 donor cells 
was successfully transferred.
Survival curves of normal control cells MRG5 and 
GM7166VA7 and of the microcell hybrid clones of 
11/1, 11/21, and 11/41 are presented in figure 2. 
GM7166VA7 cells were highly sensitive to radiation, 
compared with normal cells, and this sensitivity was 
unchanged even after the transfer of an extra copy of 
normal chromosome 11. Although only three microcell 
hybrid clones are shown in figure 2, all of the seven 
clones that we generated lacked any restoration of radia­
tion resistance. This is in contrast to the previous obser­
vation with AT cells, where AT5BIVA and AT4B1NE1.3
cells containing an additional chromosome 11 from 
A9(neol 1)-1 cells had normal levels of radiation sensi­
tivity (Komatsu et al. 1990; jongmans et al. 1995), Since 
analysis of microsatellite DNA and karyotyping proved 
successful chromosome transfer of chromosome 1 I, and 
since A9(neo!T)-l cells were adequate donors for func­
tional complementation studies with AT, our results in­
dicate that the gene responsible for NBS V2 is not
on chromosome 11 (it is a single human
c o
oCti
Ö) 
c  
>
>  
3  
(/)
Dose/Gy
Figure 2 Survival curves for X-irradiated GM7166VA7 cells, 
control MRC15 cells, and microccll hybrid clones containing an addi­
tional human chromosome 1 1 : 1 1 / 1, 1 1 /2 1 , and 1 1/41.
Letters to the Editor 887
Hybrid clone 3 
j
Hybrid clone 1
ATSBIVA(neo) 
(AT)
1
Dose/Gy
Figure 3 Survival curves of X-irradiated hybrid clones 1 and
3, produced by somatic cell fusion between GM7166VA7(gpt) and 
AT5BIVA(neo), and of both the parental cells.
chromosome that complements radiation sensitivity of 
AT in all complementation groups; Jongmans et ah
1995).
The genetic heterogeneity of both diseases is sup­
ported by functional complementation of hybrid cells 
generated by fusing NBS cells and AT-D cells. All hybrid 
clones independently obtained by somatic cell fusion of 
GM7166VA7(gpt) and AT5BIVA(neo) exhibited a sig­
nificant restoration of radiation resistance, as shown in 
figure 3. This result is in agreement with that of haplo- 
type studies of sib pairs with NBS that use polymorphic 
markers of chromosome H q22-23 from the AT region. 
The alleles of affected siblings did not match in any of 
the six families with NBS (whether VI and V2) (Stumm 
et al. 1995). Taken together, these results indicate that 
the locus of the NBS V2 gene is genetically distinct from 
the AT locus on chromosome 11 and, therefore, that 
the ATM-gene is not implicated in NBS,
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Codon 219 Polymorphism of PRNP in Healthy 
Caucasians and Creutzfeldt-Jakob Disease Patients
To the Editor:
A number of point and insert mutations of the PrP gene
allele frequency of 6%. This polymorphism results in 
the substitution of the most common negatively charged 
glutamic acid by the positively charged lysine. They also 
reported one GSS family whose affected members car­
ried the GSS-related codon 102 mutation and the poly­
morphic lysine at codon 219 on the same allele. The 
authors stated that the clinicopathological features of 
these patients clearly differ from those of previously re­
ported GSS patients with codon 102 mutation (Furu- 
kawa et al. 1995), These findings prompted us to analyze 
this polymorphism in our control and CJD Caucasian 
populations*
To determine the incidence of codon 219 polymor­
phism, we screened DNA samples of the following: 100 
randomly selected unrelated healthy adult individuals of 
both sexes, collected from all over Italy; 59 sporadic 
CJD patients with no known PRNP mutation (in 36 
patients the clinical diagnosis was confirmed by neuro- 
pathological examination and/or western blot detection 
of the disease-specific, partially protease-resistant, prion 
protein); 8 familial CJD patients with codon 210 muta­
tion; 2 familial CJD patients with codon 200 mutation; 
and 1 GSS patient with codon 102 mutation. We also 
screened 34 healthy members (mutated and nonmutated 
individuals) of these families.
DNA was extracted from blood, according to stan-
(PRNP) have been linked to familial Creutzfeldt-Jakob dard procedures. Since the substitution of G by A in the 
disease (CJD) and Gerstmann-Sträussler-Scheinker dis- first position of codon 219 of PRNP (Ghr^Lys) does 
ease (GSS) (for a review, see Pocchiari 1994; Goldfarb not create or abolish any restriction site, the restriction 
and Brown 1995). Moreover, the methionine/valine ho- site-generated PCR was used to screen for the presence 
mozygosity at the polymorphic codon 129 of PRNP may of this polymorphism. A mismatched sense primer (Sc- 
cause a predisposition to sporadic (Palmer et al. 1991; 7) containing a C~>A change at nucleotide 650 and a 
Salvatore et al. 1994) and iatrogenic (Collinge et al, matched antisense primer (Sc~4) were prepared as de- 
1991; Brown et al. 1994) CJD or may control the age scribed elsewhere (Furukawa et a l  1995). This substitu­
ât onset of familial cases carrying either the 144-bp in- tion creates a restriction site for BsiW I (98 and 20 bp, 
sertion (Pouker et al. 1992) or codon 178 (Goldfarb et respectively) in the PCR product (118 bp) only when 
al. 1.992), codon 198 (Hsiao et al. 1989), and codon the G nucleotide is present in the first position of codon 
210 (Pocchiari et al. 1993) pathogenic mutations in 219. The accuracy of the test was assessed by using DNA  
PRNP. In addition, the association of methionine or samples whose entire open reading frames of PRNP were 
valine at codon 129 and the point mutation at codon fully sequenced (Pocchiari et al. 1993; Barbanti et al.
178 on the same allele seem to play an important role 
in determining either fatal familial insomnia or CJD
1994).
All 100 Italian controls had Glu/Glu at codon 219,
(Goldfarb et al. 1992). However, it is noteworthy that with a Ghr.Lys allele frequency of 1:0, significantly dif- 
a relationship between codon 129 polymorphism and ferent from that in the Japanese population (.94:.06; P
accelerated pathogenesis (early age at onset or shorter .004, Fisher exact test; Furukawa et al, 1995). More-
duration of the disease) has not been seen in familial over, none of the 59 sporadic CJD patients, 11 familial 
CJD patients with codon 200 mutation (Gabizon et al. CJD/GSS patients, or 34 healthy members of these fami- 
1993) or in GSS patients with codon 102 mutation (Bar- lies showed the polymorphic lysine at codon 219.
banti et al. 1994; Hainfellner et al. 1995), arguing that 
other, as yet unidentified, gene products or environmen­
tal factors, or both, may influence the clinical expression 
of these diseases.
This discrepancy may be related to ethnic back­
ground. However, the finding that the Japanese and 
Caucasian populations have different gene frequencies 
at the polymorphic codons 219 and 129 (Owen et al. 
Recently, Furukawa et al. (1995) found a new G~+A 1990; Doh-ura et al. 1991) may be highly relevant in
polymorphism in the first position of codon 219 of 
PRNP in 12 of 100 healthy Japanese people, with an
the clinicopathological phenotype of CJD and related 
disorders. This is supported by the different influence
